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ABSTRACT: The neutral Rh(I)−Xantphos complex [Rh-
(κ3-P,O,P-Xantphos)Cl]n, 4, and cationic Rh(III) [Rh(κ
3-P,O,P-
Xantphos)(H)2][BAr
F
4], 2a, and [Rh(κ
3-P,O,P-Xantphos-3,5-
C6H3(CF3)2)(H)2][BAr
F
4], 2b, are described [Ar
F = 3,5-
(CF3)2C6H3; Xantphos = 4,5-bis(diphenylphosphino)-9,9-
dimethylxanthene; Xantphos-3,5-C6H3(CF3)2 = 9,9-dimethyl-
xanthene-4,5-bis(bis(3,5-bis(triﬂuoromethyl)phenyl)-
phosphine]. A solid-state structure of 2b isolated from C6H5Cl
solution shows a κ1-chlorobenzene adduct, [Rh(κ3-P,O,P-
Xantphos-3,5-C6H3(CF3)2)(H)2(κ
1-ClC6H5)][BAr
F
4], 3. Ad-
dition of H2 to 4 aﬀords, crystallographically characterized, [Rh(κ
3-P,O,P-Xantphos)(H)2Cl], 5. Addition of diphenyl acetylene to
2a results in the formation of the C−H activated metallacyclopentadiene [Rh(κ3-P,O,P-Xantphos)(ClCH2Cl)(σ,σ-(C6H4)C(H)
CPh)][BArF4], 7, a rare example of a crystallographically characterized Rh−dichloromethane complex, alongside the Rh(I)
complex mer-[Rh(κ3-P,O,P-Xantphos)(η
2-PhCCPh)][BArF4], 6. Halide abstraction from [Rh(κ
3-P,O,P-Xantphos)Cl]n in the
presence of diphenylacetylene aﬀords 6 as the only product, which in the solid state shows that the alkyne binds perpendicular to
the κ3-POP Xantphos ligand plane. This complex acts as a latent source of the [Rh(κ3-P,O,P-Xantphos)]
+ fragment and facilitates
ortho-directed C−S activation in a number of 2-arylsulﬁdes to give mer-[Rh(κ3-P,O,P-Xantphos)(σ,κ1-Ar)(SMe)][BArF4] (Ar =
C6H4COMe, 8; C6H4(CO)OMe, 9; C6H4NO2, 10; C6H4CNCH2CH2O, 11; C6H4C5H4N, 12). Similar C−S bond cleavage is
observed with allyl sulﬁde, to give fac-[Rh(κ3-P,O,P-Xantphos)(η
3-C3H5)(SPh)][BAr
F
4], 13. These products of C−S activation
have been crystallographically characterized. For 8 in situ monitoring of the reaction by NMR spectroscopy reveals the initial
formation of fac-κ3-8, which then proceeds to isomerize to the mer-isomer. With the para-ketone aryl sulﬁde, 4-SMeC 6H4COMe,
C−H activation ortho to the ketone occurs to give mer-[Rh(κ3-P,O,P-Xantphos)(σ,κ1-4-(COMe)C6H3SMe)(H)][BArF4], 14. The
temporal evolution of carbothiolation catalysis using mer-κ3-8, and phenyl acetylene and 2-(methylthio)acetophenone substrates
shows initial fast catalysis and then a considerably slower evolution of the product. We suggest that the initially formed fac-isomer
of the C−S activation product is considerably more active than the mer-isomer (i.e., mer-8), the latter of which is formed rapidly
by isomerization, and this accounts for the observed diﬀerence in rates. A likely mechanism is proposed based upon these data.
1. INTRODUCTION
The transition-metal chemistry associated with diphosphine,
and related, pincer ligands is signiﬁcant to many areas of
organometallic chemistry, catalysis, and materials science. This
is due to the attractive properties that such ligands give the
resulting metal complexes, for example: stability, electronic and
steric variability, and, in some cases, metal−ligand coopera-
tivity.1−5 Central to many of these studies have been systems
based around “PCP” and “PNP”-type ligand scaﬀolds (Figure
1). These provide relatively rigid ligand environments, that
often result in mer-κ3-coordination geometries at the metal
center. A less explored class of pincer ligand comes from POP-
frameworks based upon the Xantphos-motif (Xantphos = 4,5-
bis(diphenylphosphino)-9,9-dimethylxanthene, Figure 1),6,7
that although originally developed to be cis-chelating bidentate
phosphine ligands can also act as mer-κ3 8 or, less commonly,
fac-κ3 POP-pincer ligands.9 Recently there has been signiﬁcant
interest in the chemistry associated with Xantphos acting as a
POP-pincer ligand to the group 9 metals (Figure 2), for
example in carbonylation (A),9 activation of H2/alkenes (B−
D),10−12 silylation (E),13 hydroamination (F),14 hydroacylation
(G),15 and amine−borane dehydrocoupling and hydroboration
processes (H).16−18
We have recently reported the use of the [Rh(Xantphos)]+
catalyst fragment in carbothiolation reactions between alkynes
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Figure 1. M(PCP), M(PNP), and M(POP) metal−ligand motifs.
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and ketone-bearing aryl sulﬁdes to produce alkenyl sulﬁde
products (Scheme 1).19 These catalyst systems operate best at
elevated temperatures, e.g. coupling phenyl acetylene and 2-
(methylthio)acetophenone at 373 K in chlorobenzene or
dichloroethane solvent. In addition to this atom-eﬃcient C−
C and C−S bond formation process, the resulting alkenyl
sulﬁde can be used for further functionalization, i.e. functional
group recycling. This Xantphos system delivers improved yields
and conversion times compared to our previously reported
DPEphos system20 [cf. Xantphos 99%, 2 h; DPEphos 90%, 24
h, Scheme 1, DPEphos = oxidi-2,1-phenylene-bis-
(diphenylphosphine)]. For the DPEphos catalyst, in situ
NMR spectroscopic studies identiﬁed the C−S activated
intermediates fac-κ3-I and mer-κ3-J to be in equilibrium with
one another at 298 K, while at 333 K mer-κ3-J was the observed
resting-state during catalysis.20
Transition-metal-catalyzed C−S activation processes are
becoming increasingly important in synthesis,21 especially
their use in cross coupling reactions.22−26 In this contribution
we describe a study of the C−S activation processes occurring
in the [Rh(Xantphos)][BArF4] system. We also report a new,
readily accessible, Rh(I)−Xantphos precursor complex which
has a labile alkyne ligand; report C−H activation processes
mediated by this fragment; and also make comment upon the
likely active species in carbothiolation catalysis.
2. RESULTS AND DISCUSSION
2.1. Synthesis of Rh(I) Precursor Complexes. A suitable
entry point into the C−S activation chemistry would be a Rh(I)
precursor that can promote oxidative addition of the ketosulﬁde
substrate. Previously in the DPEphos system we used the ortho-
xylene-ligated [Rh(κ2-P,P-DPEphos)(o-xylene)][BAr
F
4] as a
suitable precursor. This was generated by addition of H2 to
the corresponding NBD complex in o-xylene (NBD =
norbornadiene).20 Noting that our recent report of the alkyne
carbothiolation catalyzed by [Rh(Xantphos)]+ used chloroben-
zene as a solvent, we targeted an appropriate precursor that
involved this as a ligand. Addition of H2 to previously reported
cis-[Rh(κ2-P,P-Xantphos)(NBD)][BAr
F
4], 1a,
15 in C6H5Cl
solvent resulted in the quantitative formation of a Rh(III)
dihydride complex [Rh(κ3-P,O,P-Xantphos)(H)2][BAr
F
4], 2a, as
characterized by in situ 1H and 31P{1H} NMR spectroscopy
(Scheme 2), which is analogous to recently reported variants
Xantphos-tBu11 or Xantphos-iPr11. Complex 2a could not be
isolated as a solid. However, treatment of the 3,5-C6H3(CF3)2
P-substituted Xantphos analog of 1a (complex 1b) with H2 in
C6H5Cl solution led to the isolation of [Rh(κ
3-P,O,P-Xantphos-
3,5-C6H3(CF3)2)(H)2(κ
1-ClC6H5)][BAr
F
4], 3, as a white
crystalline solid in 79% yield. The solid-state structure of the
cation as determined by single crystal X-ray diﬀraction is shown
in Figure 3.
Figure 2. Representative examples of κ3-Xantphos complexes.
Scheme 1. Carbothiolation Using Rh−DPEphos and
Xantphos Catalystsa
a[BArF4]
 anions are not shown.
Scheme 2. Synthesis of Rh(III) Dihydride Xantphos Complexesa
a[BArF4]
 anions are not shown.
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The solid-state structure of 3 shows a cis-dihydride species
(the hydrides were located in the diﬀerence map), with a κ1-
chlorobenzene [Rh−Cl 2.5207(12) Å] and a mer-κ3-Xantphos
ligand. Complex 3 is closely related to similar compounds in
which acetone, MeCN,15 or H3B·NMe3
16 replace the
chlorobenzene ligand, and the gross structural metrics are
similar to these adducts. In the 1H NMR spectrum of complex
3 in C6D5Cl solution, a single environment, indicated by a
broad signal at δ −17.7, is observed for the hydride ligand, and
a single Xantphos-methyl signal (6 H) is observed. A single
environment showing coupling to 103Rh [δ 45.3, J(RhP) = 118
Hz] is also observed in the 31P{1H} NMR spectrum. These
data suggest a time-averaged C2v symmetry for the metal
fragment, likely approximated to a 5-coordinate “Y-shaped”
[Rh(κ3-P,O,P-Xantphos-3,5-C6H3(CF3)2)(H)2][BAr
F
4], i.e. 2b.
When complex 3 is dissolved in CD2Cl2, a signal assigned to
free C6H5Cl is observed, in addition to very similar NMR
spectroscopic data to 2a in CH2Cl2 solution. Complexes 2a/b
in solution, or 3 in the solid state, do not lose H2 on application
of a vacuum (∼10−3 Torr). Cooling of 3 (183 K, CD2Cl2) did
not result in a 1H NMR spectrum that reﬂects the solid-state
structure (i.e., inequivalent hydrides were not observed). This is
in contrast to [Rh(κ3-P,O,P-Xantphos)(H)2(acetone)][BAr
F
4],
15
in which the hydrides are equivalent at 298 K but inequivalent
at low temperature, which is suggested to be due to reversible
decoordination of acetone. Given these data, we suggest that
complex 3 exists in C6H5Cl or CD2Cl2 solution predominantly
as [Rh(κ3-P,O,P-Xantphos-3,5-C6H3(CF3)2)(H)2][BAr
F
4], 2b,
but can be recrystallized from C6H5Cl solvent to give the
solvent adduct 3. We discount a time-averaged six-coordinate
complex with trans-hydrides as this would likely have a
chemical shift for the hydride ligands at higher ﬁeld than is
observed [e.g., [Rh(κ3-P,O,P-Xantphos-
tBu)(H)2(OH2)][SbF6] δ
−9].11 Complex 3 adds to the very small number of
crystallographically characterized κ1-chlorobenzene com-
plexes.27 We cannot comment on whether a similar complex
would be formed with 2a, as we have been unable to produce
crystalline material suitable for analysis.
As noted recently by Goldman, the formation of a Rh(III)
dihydride complex over a Rh(I) species on addition of H2 could
well be due to the relatively weak trans-inﬂuence of the POP−
ether ligating group in Xantphos that favors the product of
oxidative addition of H2.
11 In addition to this, wide-bite angle
ligands such as Xantphos will tend to favor Rh(III)
(dihydrides) over Rh(I) species.28 Thus, avoiding the use of
H2 in the production of the precursor for C−S activation would
thus be advantageous in generating a Rh(I) precursor. To
accomplish this, addition of Xantphos to [Rh(COE)2Cl]2
(COE = cyclooctene) in C6H6 solution resulted in the
formation of an insoluble (benzene) material that we
tentatively characterize as the Rh(I) complex [Rh(Xantphos)-
Cl]n, 4, presumably formed as a coordination polymer with
bridging halide ligands (Scheme 3), based upon its insolubility.
This material analyzed correctly for composition by elemental
analysis. Dissolution in CH2Cl2 resulted in a mixture of,
uncharacterized, products. Interestingly, the analogous com-
Figure 3. Solid-state structure of the cations in complexes 3 (left) and 5 (right). Displacement ellipsoids are shown at the 50% probability level. Most
hydrogen atoms are not shown. Selected bond lengths (Å) and angles (deg): (3): Rh1−P1, 2.2673(12); Rh1−P2, 2.2707(13); Rh1−Cl1,
2.5207(12); Rh1−O1, 2.249(3); P1−Rh1−P2, 161.03(4); O1−Rh1−C1, 90.16(8). (5): Rh1−P1, 2.2591(10); Rh1−P2, 2.2779(11); Rh1−Cl1,
2.4625(11); Rh1−O1, 2.248(3); P1−Rh1−P2, 163.85(4); O1−Rh1−C1, 86.87(8).
Scheme 3. Scheme Relating the Synthesis of Complexes 4, 5,
6, and 7a
a[BArF4]
 anions are not shown.
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plexes with Xantphos−tBu11 or Xantphos−iPr12 are soluble in
benzene and shown to be monomers in the solid state. This
presumably reﬂects the diﬀering steric demands of the P-
substituents. Suspension of complex 4 in toluene and addition
of H2 resulted in the formation of the neutral, soluble, Rh(III)
cis-dihydride complex Rh(κ3-P,O,P-Xantphos)(H)2Cl, 5, ob-
tained in 79% yield (Scheme 3) as colorless crystals. The
solid-state structure of 5 is shown in Figure 3 and is very closely
related to recently reported Rh−Xantphos−tBu11 and Ir−
Xantphos−iPr12 analogues (i.e., B Figure 2). The NMR
spectroscopic data for 5 are in full accord with the solid-state
structure and show inequivalent hydride environments in the
1H NMR spectrum, in contrast to complex 3. The formation of
5 in good yield from simple addition of H2 to 4 further
supports the latter’s formulation.
Removal of the chloride ligand in 4 is easily achieved by
treatment of a suspension in 1,2-C6H4F2 solvent with
Na[BArF4] in the presence of a slight excess of diphenylactylene
to yield the Rh(I) complex mer-[Rh(κ3-P,O,P-Xantphos)(η
2-
PhCCPh)][BArF4], 6, as orange crystalline material in good
(82%) yield on work-up. The solid-state structure of the cation
in complex 6 is shown in Figure 4, and this shows the alkyne to
be bound perpendicular to the Rh−POP plane (angle between
planes = 90.7°). The C−C distance [1.256(6) Å] is lengthened
compared to free ligand [1.206(2) Å29]. The NMR
spectroscopic and microanalytical data support this formula-
tion; for example, a single environment is observed at δ 20.4 [d,
J(RhP) = 124 Hz] in the 31P{1H} NMR spectrum, while one,
relative integral 6 H, signal is observed for the Xantphos methyl
groups. There are surprisingly few pseudo square planar
complexes reported which have pincer ligands and bound
alkynes or alkenes. One example is (PCP)Ir(trans-1,4-phenyl-
but-3-ene-1-yne) [PCP = (κ3-C6H3-2,6-(CH2P
tBu2)2)], which
also adopts a similar coordination mode with the metal−pincer
fragment to 6 and shows a similar C−C distance [1.270(4)
Å].30 Complex 6 represents an excellent starting point into the
C−S activation chemistry, which is described in the next
section.
An alternative methodology for generating complex 6 is
addition of H2 (1 atm) to complex 1a in CH2Cl2 solution to
form complex 2a, evacuation, followed by addition of a CH2Cl2
solution of diphenylacetylene (Scheme 5). Under these
conditions of excess alkyne, cis-stilbene is also observed to be
formed by 1H NMR spectroscopy [δ 6.57]. Also produced is a
parallel product, identiﬁed by NMR spectroscopy and single
crystal X-ray diﬀraction as [Rh(κ3-P,O,P-Xantphos)(ClCH2Cl)-
(σ,σ-(C6H4)C(H)CPh)][BArF4], 7. Complex 7 is formed as
a major product relative to 6 under these conditions (relative
ratio 2:1 of 7 to 6). Although single crystals of complex 7 could
be produced in this manner, in bulk form it was always
contaminated with some 6.
The solid-state structure of 7 (Figure 4) shows a trans-
stilbene-derived ligand that has additionally undergone C−H
activation to give a metallacyclopentadiene [Rh−C 2.010(4)
and 2.020(4) Å]. Similar activation of diphenylactylene has
been reported at Rh and Ir centers,31,32 and the structural
metrics previously reported for these metallacyclopentadienes
are similar to 7. The coordination sphere of the metal is
completed by a coordinated CH2Cl2 ligand [Rh−Cl, 2.393(7)
Å]. Complexes in which CH2Cl2 acts as ligand are now well−
established,33 and a handful of examples with Rh have been
reported.34−37 The 1H and 31P{1H} NMR data for complex 7
(CD2Cl2 solution) are in full accord with the solid-state
structure. In particular, the 1H NMR spectrum shows
inequivalent Xantphos methyl groups, and signals that can be
attributed to the metallocycle unit. Signals due to the
coordinated CH2Cl2 ligand were not observed, but it is likely
that this ligand is in rapid exchange with the bulk solvent.33 The
31P{1H} NMR spectrum displays a single environment as a
doublet, showing coupling to 103Rh consistent with coordina-
tion with a Rh(III) center [J(RhP) = 119 Hz] and a mirror−
plane of symmetry in solution.
Figure 4. Solid-state structure of complexes 6 (left) and 7 (right) showing the cations only. Displacement ellipsoids are shown at the 50% probability
level. Most hydrogen atoms are not shown. Selected bond lengths (Å) and angles (deg): (6): Rh1−P1, 2.2825(12); Rh1−P2, 2.2896(12); Rh1−
C46, 2.114(4); Rh1−C47, 2.094(4); Rh1−O1, 2.138(3); C46−C47, 1.256(6); P1−Rh1−P2, 166.65(4); O1−Rh1−C46, 166.73(15); O1−Rh1−
C47, 158.46(15). (7): Rh1−P1, 2.3036(11); Rh1−P2, 2.2969(10); Rh1−C40, 2.010(4); Rh1−C47, 2.020(4); Rh1−O1, 2.223(3); C45−C56,
1.447(7); C46−47, 1.348(7); Rh1−Cl200, 2.393(7); Cl200−C201, 1.788(7); C201−Cl202, 1.781(7); P1−Rh1−P2, 163.83(4); O1−Rh1−C40,
94.81(14); O1−Rh1−C47, 176.11(15). Only the major disordered competent of the CH2Cl2 ligand is shown.
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The observation that complex 7 is preferentially formed over
complex 6 when complex 2a is formed in situ suggests that this
latter Rh(III) complex is central to the C−H activation process
to form 7. Complex 6 does not undergo C−H activation to
form 7 (Scheme 4), supporting this hypothesis. The C−H
activation process can be reversed. Complex 7 reacts with H2 (1
atm) slowly (12 h, CD2Cl2) to form complex 2a as determined
by 31P{1H} NMR spectroscopy. No cis-stilbene was observed to
be formed [δ 6.57, CDCl3] under these conditions, and when
the reaction was performed with D2, signals at δ 7.25 and 7.57
were observed in the 2H NMR spectrum, consistent with
formation of trans-PhCHC(D)(C6H4D) [lit. 1H δ 7.19, 7.60
CDCl3
38]. d2-2a was also observed to be formed by a broad
signal at ∼δ −18 in the 2H NMR spectrum. This shows that
under conditions exogenous of H2, complex 7 can be recycled
back to form 2a, but only slowly.
A suggested mechanism for the formation of complex 7 is
shown in Scheme 5. Addition of H2 to 1a forms the dihydride
complex 2a, which then undergoes coordination and hydride
insertion with diphenylacetylene to give the corresponding cis-
diphenylvinyl intermediate. The pathway then bifurcates:
Elimination of cis-stilbene (observed) and subsequent coordi-
nation of diphenylacetylene eventually give 6. Alternatively a
cis−trans isomerization (possibly via a metallacyclopropene
intermediate)31,39 followed by C−H activation at the ortho-
position of arene occurs, likely via a sigma−CAM process
(sigma−complex assisted metathesis),40 loss of H2, and
coordination of CH2Cl2 to form 7.
2.2. C−S Activation Chemistry. With a suitable Rh(I)
precursor to C−S activation in hand in complex 6, reactivity
with a variety of arylsulﬁdes was explored (Figure 5). Given the
use of the substrate I [2-(methylthio)acetophenone] in our
recently reported carbothiolation chemistry,19,20 initial studies
focused upon using this starting material. Addition of I to a
toluene solution of 6 resulted, at 298 K, in the formation of a
mixture of two isomers, identiﬁed spectroscopically as fac- and
mer-[Rh(κ3-P,O,P-Xantphos)(σ,κ
1-C6H4COMe)(SMe)][BAr
F
4],
8, Scheme 6. These isomers were initially formed in a 20:1 ratio
respectively after 20 min and equilibrated over time to give κ3-
mer-8 as the thermodynamic product after 32 h. This process
may be accelerated by heating to 373 K for 40 min, after which
time κ3-mer-8 can be isolated in good (70%) yield as the only
product. In both cases free diphenylacetylene is also observed
to be formed. The 31P{1H} NMR spectrum of κ3-fac-8 shows
two environments, each with a distinctive doublet of doublet
coupling pattern, that show two very diﬀerent magnitudes of
coupling to 103Rh: δ 34.8 [J(RhP) = 150, J(PP) = 17 Hz] and δ
22.6 [J(RhP) = 104, J(PP) = 17 Hz]. Such a pattern is
characteristic of 31P environments in which one sits opposite to
a high trans inﬂuence ligand (such a SMe) while one sits
opposite a weaker ligand, i.e. the ketone.39,41 The 1H NMR
spectrum shows two signals at δ 1.56 and 1.43 (both of relative
integral 3 H) as doublets [J = 7.6 and 1.2 Hz, respectively].
These are assigned to the SMe and ketone−methyl group,
respectively, and the larger coupling to 31P in the former
(conﬁrmed by selective decoupling experiments) is fully
consistent with its trans disposition to a phosphine.20,39
Although we have not obtained a solid-state structure for κ3-
fac-8, similar complexes have been crystallographically charac-
terized with DPEphos.10,39,41 The NMR data for κ3-mer-8 are
also fully consistent with its formulation; notably, a single
environment is observed in the 31P{1H} NMR spectrum
[J(RhP) = 106 Hz], and the SMe [δ 0.87] and ketone−methyl
groups [δ 1.99] are observed as singlets in the 1H NMR
spectrum; consistent with their now cis-relationship with the
phosphines. Two methyl environments are observed for the
Xantphos ligand. The solid-state structure of κ3-mer-8 is shown
in Figure 6. In the unit cell there are two crystallographically
distinct cations, for which the structural metrics are very similar.
The structure demonstrates the κ3-mer geometry of the ﬁnal
product, in which the thiomethyl and aryl groups sit mutually
Scheme 4. Reactivity of Complex 7a
a[BArF4]
 anions are not shown.
Scheme 5. Suggested Mechanism for the Formation of
Complex 7a.
a[BArF4]
 anions are not shown. Xantphos is abbreviated POP.
Figure 5. Arylsulﬁdes used in this study.
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cis with one another [Rh1−C40, 1.975(5); Rh1−S1,
2.3373(14) Å]. The remaining coordination site on the Rh(III)
center is occupied by a dative bond from the ortho substituent
on the arene [Rh1−O1, 2.102(3) Å]. The thiomethyl group sits
syn to one phosphine and anti to the other, and it is likely that
low energy libration around the Rh−S bond gives the cation
time-averaged Cs symmetry in solution.
Exchange between isomers of Xantphos, in which the
phosphines adopt a cis or trans geometry, has been noted
previously, and in some cases this is reversible.10,42,43 For the
system fac/mer-[Rh(κ3-P,O,P-Xantphos)(PCyp3)(H2)][BAr
F
4],
equilibrium measurements indicate that the fac isomer is
preferred and that although enthalpically there is little
diﬀerence between the isomers, entropic considerations
determine the ﬁnal position of the equilibrium (ΔS is positive
for the generation of the fac isomer).10 On heating mer-8 (373
K, C6D5CD3), we saw no evidence, to the detection limit of
31P
NMR spectroscopy, for fac-8. However, we cannot discount its
formation at a very low equilibrium concentration under these
conditions.
Using the protocol for the isolation of pure C−S activated
product developed above, the 2-arylmethylsulﬁdes II−V were
combined with complex 6 to aﬀord complexes 9−12 in good
yields (66%−78%), all as the mer-isomers, Scheme 7. These
red/brown complexes have been characterized by NMR
spectroscopy, ESI−MS, microanalysis, and X-ray crystallog-
raphy (apart from complex 9, in which extensive disorder of the
cation precluded a reliable analysis). Solid-state structures of
the cations in complexes 10 and 11 are shown in Figure 7
(complex 12 is presented in the Supporting Materials) and are
closely related to that of mer-8. For the structures 10−12, the
activated thio−aryl ligand is equally disordered between two
orientations in which the SMe and ortho-coordinating groups
have swapped positions, giving the overlaid disordered
structures C2v symmetry in the solid state. Although this
disorder could be modeled satisfactorily, this does mean that
caution should be exercised in the interpretation of the ﬁne
details of the structural metrics around the metal. Nevertheless,
the structures conﬁrm the formulation.
When allyl phenyl sulﬁde VI is combined with complex 6,
the C−S activated product fac-[Rh(κ3-P,O,P-Xantphos)(η3-
C3H5)(SPh)][BAr
F
4], 13, is isolated as a green crystalline
solid in 60% yield, Scheme 8. The solid-state structure of 13 is
shown in Figure 8 and demonstrates the κ3-fac geometry of the
Xantphos ligand [Rh1−O1, 2.200(2) Å, P−Rh−P 109.54(3)°]
and the η3 coordination mode of the allyl group at the Rh(III)
Scheme 6. Formation of fac-8 and mer-8a
a[BArF4]
 anions are not shown.
Figure 6. Solid-state structure of complex mer-8 showing the cation
only. Only one of the crystallographically independent cations is
shown. Displacement ellipsoids are shown at the 50% probability level.
Hydrogen atoms are not shown. Selected bond lengths (Å) and angles
(deg): Rh1−P1, 2.2983(16); Rh1−P2, 2.3068(16); Rh1−O1,
2.102(3); Rh1−O2, 2.215(3); Rh1−S1, 2.3373(14); Rh1−C40,
1.975(5); P1−Rh−P2, 165.22(5); O1−Rh1−P1, 90.08(10); O1−
Rh1−S1, 173.00(10).
Scheme 7. Products of Reaction with the 2-
Arylmethylsulﬁdes Used in This Studya,b
aCH2Cl2 at 298 K.
b[BArF4]
 anions are not shown.
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center. The molecule has, noncrystallographically imposed,
pseudomirror symmetry. The solution NMR data for 13 are
consistent with this, with one 31P environment observed
[J(RhP) = 132 Hz], while the allyl ligand is revealed by three
signals in a 1:2:2 ratio [multiplets centered at δ 4.80, 3.99,
2.64]. Oxidative addition of allyl sulﬁdes to late transition
metals is known.44,45 Presumably this process occurs via initial
coordination of the alkene followed by oxidative cleavage of the
C−S bond.44 Very few examples of crystallographically
characterized Xantphos (or DPEphos) complexes that also
contain allyl ligands have been reported, and all have a κ2-P,P
geometry of the chelate ligand,46 diﬀerent from the κ3-POP
observed for complex 13.
The reaction of (4−methylthio)acetophenone VII with
complex 6 probes the requirement for a ortho-directing group
in these C−S activations, Scheme 8. The product of this
reaction is mer-[Rh(κ3-P,O,P−Xantphos)(σ,κ1-C6H3(COMe)-
SMe)(H)][BArF4], 14, isolated in moderate yield (38%) as
colorless crystalline material, for which NMR spectroscopy and
a single crystal X-ray diﬀraction study showed it to be the
product of C−H activation ortho to the directing ketone group.
The 1H NMR data for 14 show a single hydride environment at
δ −14.99 (relative integral 1 H) as a doublet of triplets and the
absence of a methyl resonance below δ 1 that would be
indicative of a Rh−SMe group. The 31P{1H} NMR spectrum
displays a single environment showing coupling to a Rh(III)
center [δ 39.5, J(RhP) = 114 Hz]. These data suggest C−H
activation has occurred rather than C−S activation, and the
solid-state structure derived from a single crystal X-ray analysis
conﬁrms this, Figure 8. This shows that the 4-(methylthio)-
acetophenone has undergone C−H activation ortho to the
ketone to aﬀord a cis-hydridoaryl motif, with the hydride ligand
located in the ﬁnal Fourier diﬀerence map. The rhodium’s
coordination sphere is completed by coordination of the ketone
through a dative bond, similar to that observed for the C−S
activated products. Such reactivity is directly related to the
directed activation of ortho-C−H bonds ﬁrst reported by
Murai,47 in which arylketones underdo hydroarylation with
alkenes.48 Complex 14 does not react further with alkynes, for
example phenyl acetylene.
2.3. Alkyne Trimerization. Complex 6 does not react
further with diphenylacetylene. However, it does react slowly
(20 h, 298 K) with phenylacetylene to aﬀord the products of
cyclotrimerization, 1,2,3-Ph2C6H3 and 1,2,4-Ph3C6H3, as
identiﬁed by 1H NMR spectroscopy and GC−MS. These are
formed in a 2:1 ratio (Scheme 9). Complex mer-8 will also
promote this process, but only at elevated (373 K) temperature,
and there is no reaction at 298 K. This latter reaction
presumably occurs via initial carbothiolation to release the
alkenyl sulﬁde product (observed by 1H NMR spectroscopy),
and the resulting [Rh(Xantphos)]+ fragment is then free to
Figure 7. Solid-state structure of complexes 10 (left) and 11 (right) showing the cations only. Only one disordered component of each is shown.
Displacement ellipsoids are shown at the 50% probability level. Hydrogen atoms are not shown. Selected bond lengths (Å) and angles (deg): (10):
Rh1−P1, 2.3143(7); Rh1−O1, 2.200(2); Rh1−O2, 2.133(3); Rh1−S1, 2.3074(10); Rh1−C10, 1.967(4); P1−Rh−P1′, 165.07(3); O1−Rh1−P1,
82.690(17); O2−Rh1−S1, 175.13(8). (11): Rh1−P1, 2.3060(9); Rh1−O1, 2.209(4); Rh1−N3, 2.173(5); Rh1−S2, 2.296(4); N3−C48, 1.397(7);
C48−C47, 1.441(6); C47−O3, 1.463(7); O3−C46, 1.339(6); C46−N3, 1.323(5); P1−Rh−P1′, 165.42(5); O1−Rh1−P1, 82.72(2); N3−Rh1−S1,
177.54(18).
Scheme 8. Synthesis of Complexes 13 and 14a
a[BArF4]
 anions are not shown.
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mediate cyclotrimerization. These trimerization products are
also observed during carbothiolation catalysis but in low relative
yield (less than 20%), meaning that although this process is
competitive with carbothiolation in this system, use of a slight
excess of alkyne (2 equiv) means that full conversion of the
ketone is achieved.
2.4. Catalysis. Under room temperature conditions (298
K) complex 6 will only slowly catalyze the carbothiolation of I
with phenyl acetylene (55% conversion at 24 h). However,
heating to 373 K results in faster turnover (6 h) with full
conversion to the alkenyl sulﬁde product. Complex mer-8 was
the only observed organometallic product during this catalysis
[by 31P{1H} NMR spectroscopy]. Starting from mer-8, the
reaction is considerably slower (16 h, 373 K), and again, mer-8
is the only observed species during catalysis. Following these
reactions by in situ NMR spectroscopy during the early stages
of catalysis using 1,3-dimethoxybenzene as internal standard
(Figure 9) revealed the temporal proﬁles for the formation of
the product for both starting pre-catalysts. For catalysts using
complex 6, initial very rapid catalysis (∼15% conversion after
20 min) is then followed by a much slower rate. These data are
consistent with the initial formation of a very active catalyst that
turns over the carbothiolation rapidly but quickly forms a less
active catalyst. We suggest, based on our stoichiometric
experiments, that this can be explained by the initial formation
of fac-8. In principle this could decoordinate its POP ether
linkage relatively easily to allow access to the alkyne to the now
16-electron metal center. Such potentially hemilabile behavior
has been noted for related Xantphos complexes on reaction
with MeCN.10 Isomerization to the presumably less active mer-
8, shown to be rapid at 373 K, results in a slower rate of
catalysis. Consistent with this, mer-8 is the only observed
organometallic species during catalysis, as the resting state,
while starting from mer-8 results in no rapid initial burst of
activity, but only slow turnover at a rate broadly similar to that
for the slow regime when starting from 6. Whether catalysis in
Figure 8. Solid-state structure of complexes 13 (left) and 14 (right) showing the cations only. Displacement ellipsoids are shown at the 50%
probability level. Most hydrogen atoms are not shown. Selected bond lengths (Å) and angles (deg), (13): Rh1−P1, 2.2847(7); Rh1−P2, 2.3337(7);
Rh1−O1, 2.200(2); Rh1−S1, 2.3393(8); Rh1−C1, 2.190(3); Rh1−C2, 2.197(3); Rh1−C3, 2.249(3); C1−C2, 1.408(5); C2−C3, 1.388(5); P1−
Rh1−P2, 109.54(3); O1−Rh1−S1 166.44(6). (14): Rh1−P1, 2.2699(6); Rh1−P2, 2.2729(6); Rh1−O1, 2.1861(17); Rh1−O2, 2.1609(18); Rh1−
C1, 1.968(3); P1−Rh1−P2, 166.45(2); O1−Rh1−P1, 83.53(5); O1−Rh1−C1, 175.74(9).
Scheme 9. Phenyl Acetylene Trimerization As Catalyzed by
Complexes 6 and mer-8
Figure 9. Time conversion plot for the catalytic reaction of I (0.1 M)
and phenylactylene (0.2 M). [cat.] = 6 or mer-8 0.005 M, solvent =
C6D5CD3, Temperature = 373 K. Both reactions reach completion.
Lines of best ﬁt are for visual comparison only.
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the slow regime occurs by a small (undetectable by 31P NMR
spectroscopy) equilibrium concentration of fac-8 or an
alternative active species is not clear. A suggested pathway for
catalysis is shown in Scheme 10. This has close similarities for
those suggested for alkyne carbothiolation20 and alkyne
hydroacylation39 using the [Rh(DPEphos)]+ system. We have
observed related intermediates previously in alkyne hydro-
acylation systems with [Rh(DPEphos)]+ fragments.39,41
Given the scatter present in the data (Figure 9), we are
reluctant to speculate further the likely rate-determining steps
or the order of reaction, and although the broad temporal
proﬁle was reproducible (e.g., mer-8 versus 6), there was
signiﬁcant variation between repeat runs with regard to the
approximate rate in the slow regime. Tests for homogeneous/
heterogeneous behavior indicated a homogeneous catalyst49
(Hg-test, sub-stoichiometric phosphine, microﬁltration tests; a
clear red solution is observed during catalysis). However, we
cannot completely rule out the presence of a small amount of
colloidal Rh-catalyst, or decomposition to a diﬀerent active
species. Notably the Hg-test still showed an initial burst of
reaction rate followed by slower turnover, consistent with our
mechanistic hypothesis. It is also interesting to note that when
catalysis is performed in dichloroethane solvent at 353 K
(rather than toluene at 373 K), a very diﬀerent proﬁle is
observed characteristic of a greater than zero order process: the
reactions are much faster and the reaction solutions are
observed to be black.19 Whether this indicates a change from
homogeneous to heterogeneous catalysis under these diﬀerent
conditions is as yet unclear, but it is notable that nanoparticle
formation has been shown to be strongly dependent on solvent
polarity.50,51
3. CONCLUSIONS
We report the synthesis of mer-[Rh(κ3-P,O,P-Xantphos)(η
2-
PhCCPh)][BArF4], 6, which acts as a latent source of the
[Rh(κ3-P,O,P-Xantphos)]
+ fragment. That this complex comes
from simple halide abstraction from [Rh(κ3-P,O,P-Xantphos)Cl]n
suggests that this might well be a useful methodology for future
synthetic and catalytic studies. Demonstrating the utility of 6 in
this regard, we have shown that it readily undergoes ketone-
directed C−S and C−H activation processes with aryl−
ketosulﬁdes. Additionally we have also reported rare examples
of Rh−chlorobenzene and Rh−dichloromethane complexes.
The temporal evolution of catalysis using 6 shows initial fast
catalysis and then and then much slower turnover, and we
suggest that the fac-isomer of the C−S activation product (i.e.,
fac-8) is considerably more active than the mer-isomer (i.e.,
mer-8), the latter being formed rapidly by isomerization. A
future strategy for optimizing this catalyzed carbothiolation
reaction might well be to limit the ﬂexibility of the ligand set so
that this isomerization does not occur, and studies are currently
ongoing to study the eﬀect of incorporating such ligands into
the catalyst structure.
4. EXPERIMENTAL SECTION
General Experimental Procedures. All manipulations, unless
otherwise stated, were performed under an argon atmosphere using
standard Schlenk and glovebox techniques. Glassware was oven-dried
at 130 °C overnight and ﬂamed under vacuum prior to use. Pentane,
dichloromethane, benzene, and toluene were dried using a Grubbs
type solvent puriﬁcation system (MBraun SPS-800) and degassed by
successive freeze−pump−thaw cycles.52 Benzene, toluene, C6H5F, and
1,2-F2C6H4 were, where appropriate, further dried over CaH2, vacuum
distilled, and stored over 3 Å molecular sieves. Chlorobenzene (less
than 0.005 H2O) was purchased from Aldrich and degassed by
successive freeze−pump−thaw cycles and stored over 3 Å molecular
sieves. Na[BArF4],
53 [Rh(COE)2Cl]2,
54 [Rh(NBD)Cl]2,
55 [Rh(κ2-P,P-
Xantphos)(NBD)][BArF4] (1a),
15 (9,9-dimethyl-9H-xanthene-4,5-
diyl)bis(3,5-bis(triﬂuoromethyl)phenyl)phosphine,56 2-(methylthio)-
acetophenone,20 4-(methylthio)acetophenone,20 2-(2-(methylthio)-
phenyl)-4,5-dihydrooxazole,57 and 2-(2-(methylthio)phenyl)-
pyridine58 were prepared by literature methods. NMR spectra were
recorded on a Bruker Avance III HD nanobay 400 MHz (Hg400) and
Bruker DPX200 spectrometer at room temperature, unless otherwise
stated. 1H NMR spectra are referenced to residual solvent signals. 31P
NMR spectra were referenced against 85% H3PO4 (external).
Chemical shifts (δ) are quoted in ppm and coupling constants (J)
in Hz. ESI-MS were recorded on a Bruker micrOTOF instrument
interfaced with a glovebox.59 Microanalysis was performed at London
Metropolitan University. Reverse phase HPLC analysis was performed
on a Ascentis Express C18, 2.7 μm column (4.6 mm × 100 mm),
eluted by gradient MeCM/H2O. GC-MS was performed on a Waters
GCT ToF mass spectrometer.
Synthesis of 2-Nitrothioanisole. To a stirred solution of 1-
ﬂuoro-2-nitrobenzene (0.268 mg, 1.9 mmol) in DMF (10 mL) was
added a sodium thiomethoxide 21% aqueous solution (2.2 mmol).
After the addition was complete, the solution was stirred at room
temperature for 2 days. Then 100 mL H2O was added to precipitate
the product. The solvent was decanted oﬀ and the resulting solid was
recrystallized (dichloromethane/petrol) to give the sulﬁde as pure
product (167 mg, 52%). The 1H NMR data is consistent with the
reported values.60
1H NMR (200 MHz, CDCl3). δ 8.26 (dd, J = 8.2 Hz, J = 1.4 Hz, 1H),
7.59 (ddd, J = 8.2 Hz, J = 7.0 Hz, J = 1.4 Hz, 1H), 7.37 (d, J = 7.6 Hz,
1H), 7.25 (ddd, J = 8.2 Hz, J = 7.2 Hz, J = 1.4 Hz 1H), 2.50 (s, 3H).
Synthesis of New Complexes: cis-[Rh(κ2-P,P-Xantphos-3,5-
C6H3(CF3)2)(NBD)][BAr
F
4] (1b). Xantphos-3,5-C6H3(CF3)2 (243 mg,
0.217 mmol) in CH2Cl2 (13 mL) was added dropwise to
[Rh(NBD)Cl]2 (50 mg, 0.108 mmol) in CH2Cl2 (1 mL). The
resulting reaction mixture was then added dropwise to Na[BArF4]
(192 mg, 0.217 mmol) in CH2Cl2 (1 mL) and the mixture was stirred
for 2 h. The solution was ﬁltered, and the ﬁltrate solvent was reduced
to ∼5 mL. Then the solution was layered with pentane (20 mL). The
solution was stored overnight at −18 °C to give the recrystallization
product. Yield = 80%, 378 mg.
Scheme 10. Suggested Catalytic Cycle for the Homogenous
Carbothiolation Catalysis Using the [Rh(Xantphos)]+
Catalyst
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1H NMR (400 MHz, CD2Cl2). δ 8.01−7.97 (m, 4H, Ar−H), 7.91 (d, J
= 7.6 Hz, 2H, Ar−H), 7.76−7.69 (m, 8H, BArF4), 7.64−7.54 (m, 8H,
Ar−H), 7.54 (s, 4H, BArF4), 7.47 (t, J = 8.0 Hz, 2H, Ar−H), 6.98−
6.92 (m, 2H, Ar−H), 4.04 (s, 4H, NBD CHCH), 3.79 (s, 2H, NBD
CH), 1.87 (s, 6H, Xantphos Me), 1.48 (s, 2H, NBD CH2).
31P{1H} NMR (160 MHz, CD2Cl2). δ 17.5 [d,
1JRhP = 148 Hz].
ESI-MS (Acetone) Positive Ion. [M]+ m/z = 1317.06 (calc.
1317.06).
Microanalysis. C86H44BF48OP2Rh (2180.88) requires: C 47.36, H
2.03; found: C 47.50, H 1.95.
[Rh(κ3-P,O,P-Xantphos)(H)2][BAr
F
4] (2a). The title compound was
prepared in situ by placing a solution of [Rh(κ2-P,P-Xantphos)(NBD)]-
[BArF4] (10 mg, 6.1 × 10
−6 mol) in CD2Cl2 (0.3 mL) under 4 atm of
hydrogen. The compound was characterized in situ by NMR
spectroscopy and ESI-MS. There was no change to the NMR
spectrum on removal of the solvent to dryness and redissolving in
CD2Cl2.
1H NMR (300 MHz, CD2Cl2). δ 7.84−7.38 [m, 38H, Ar−H + BArF4;
7.72 (8H, BArF4), 7.55 (4H, BAr
F
4), 1.73 (br s, 6H, CH3), −18.28 (dt,
2H, J(RhH) = 33, J(PH) = 12, Rh−H).
31P{1H} NMR (122 MHz, CD2Cl2). δ 41.50 (d, J(RhP) = 117).
ESI-MS (ﬂuorobenzene, 60 °C, 4.5 kV) positive ion. [M]+ m/z =
683.1250 (calc. 683.1134).
mer-[Rh(κ3-P,O,P-Xantphos-3,5-C6H3(CF3)2)(H)2(κ
1-ClC6H5)]-
[BArF4] (2b/3). 1b (50 mg, 0.023 mmol) was dissolved in
chlorobenzene (5 mL), then the solution was degassed and reacted
with hydrogen for 30 min under 4 atm. Then the solution was
degassed again and layered with hexane (10 mL). The solution was
stored overnight at −18 °C to give white solid. Yield = 79%, 40 mg.
Crystals of 3 suitable for X-ray diﬀraction were obtained from
chlorobenzene solution in situ.
1H NMR (400 MHz, CD2Cl2). δ 8.21 (s, 4H), 8.10−7.98 (br, 5H,
C6H5Cl), 7.96 (dd, J = 7.6 Hz, J = 1.2 Hz, 2H), 7.74−7.66 (m, 8H,
BArF4), 7.62 (t, J = 7.6 Hz, 2H), 7.53 (s, 4H, BAr
F
4), 7.50−7.42 (m,
2H), 7.37−7.22 (m, 8H), 1.80 (s, 6H, Xantphos Me), −17.89 (br. s,
2H).
31P{1H} NMR (160 MHz, CD2Cl2). δ 44.0 [d,
1JRhP = 119 Hz].
The following NMR spectroscopic data in C6D5Cl was obtained by
placing a solution of 1b (8 mg) in D-chlorobenzene (0.4 mL) under 4
atm of hydrogen, and characterized in situ by NMR spectroscopy.
1H NMR (500 MHz, C6D5Cl). δ 8.23−8.17 (m, 8H, BArF4), 8.15−
8.00 (m, 8H), 7.85 (s, 4H), 7.56 (s, 4H, BArF4), 7.43−7.40 (m, 2H),
7.38−7.32 (m, 2H), 7.09 (t, J = 7.5 Hz, 2H), 1.33 (s, 6H, Xantphos
Me), −17.74 (br. s, 2H). (coordinated D-chlorobenzene is not
observed).
31P{1H} NMR (200 MHz, C6D5Cl). δ 45.3 [d,
1JRhP = 118 Hz].
The 31P{1H} and 1H NMR spectra of the product in CH2Cl2 at 183
K are essentially unchanged from that in CD2Cl2 at 298 K.
Microanalysis. C85H43BClF48OP2Rh (2180.88) requires: C 46.34,
H 1.97; found: C 46.47, H 1.91.
[Rh(Xantphos)Cl]n (4). To a J. Youngs tube containing [Rh-
(COE)2Cl]2 (305 mg, 0.425 mmol) and Xantphos (492 mg, 0.85
mmol) was added 10 mL benzene, sealed, and heated to 80 °C for 4 h.
The solution changed color to dark red, followed by product
precipitation. The resulting precipitate was ﬁltered and washed with
pentane. The precipitate was dried under vacuum to yield a brick-red
powder. Yield = 91%, 555 mg. Complex 4 was insoluble in benzene,
acetone, and reacts with dichloromethane to give an unidentiﬁed
mixture. Toluene can be replaced for benzene in the procedure with
no signiﬁcant change in yield.
Microanalysis. C39H32ClOP2Rh requires: C 65.33, H 4.50; found:
C 65.41, H 4.37.
mer-[Rh(κ3-P,O,P-Xantphos)(H)2Cl] (5). The title compound was
formed by placing a solution of 4 (50 mg, 7.0 × 10−2 mmol) in toluene
(5 mL) under an atmosphere of H2 (1 atm). The solution was stirred
for 16 h at room temperature. The solution was degassed and was
reduced to ∼1 mL, 10 mL hexane was added to the solution to
precipitate the product, the solid product washed with hexane and
dried in vacuo. Yield = 79%, 40 mg. The crystals suitable for X-ray
diﬀraction were obtained by layering the benzene solution of the title
compound with hexane at room temperature.
1H NMR (400 MHz, C6D6). δ 8.34−8.22 (m, 4H, Ar−H), 7.88−7.76
(m, 4H, Ar−H), 7.44−7.33 (m, 2H, Ar−H), 7.11−6.97 (m, 8H, Ar−
H), 6.95−6.85 (m, 6H, Ar−H), 6.76 (t, J = 7.6 Hz, 2H Ar−H), 1.25 (s,
3H, Xantphos CH3), 1.15 (s, 3H, Xantphos CH3), −15.06 - −15.47
(m, 1H, Rh−H), −18.60 to −18.99 (m, 1H, Rh−H).
31P{1H} NMR (160 MHz, C6D6). δ 37.3 [d,
1JRhP = 117 Hz].
Microanalysis. C39H34ClOP2Rh (719.00) requires: C 65.15, H 4.77;
found: C 65.33, H 4.66.
mer-[Rh(κ3-P,O,P-Xantphos)(η
2-PhCCPh)][BArF4] 6. To a ﬂask
containing 4 (175 mg), Na[BArF4] (212 mg, 0.24 mmol, 1 equiv.
relative to Rh), diphenyl acetylene (51 mg, 0.29 mmol, 1.2 equiv.
relative to Rh) was added 15 mL 1,2-diﬂuorobenzene, the resulting
solution was stirred for 3 h at room temperature. The solution was
ﬁltered, and the ﬁltrate was concentrated to dryness under vacuum, the
resulting residue washed with pentane, then recrystallized by diﬀusion
of pentane into a dichloromethane solution of the crude product at
−18 °C to yield orange crystals. Yield = 82%, 340 mg.
1H NMR (400 MHz, CD2Cl2). δ 7.82 (d, J = 7.6 Hz, 2H, Ar−H),
7.74−7.71 (m, 8H BArF4), 7.55 (br, 4H BArF4), 7.45 (d, J = 7.6 Hz, 4H
Ar−H), 7.40 (t, J = 8.0 Hz, 2H Ar−H), 7.33−7.24 (m, 14H Ar−H),
7.15 (t, J = 7.2 Hz, 10H Ar−H), 7.02 (t, J = 7.6 Hz, 4H Ar−H), 1.86
(s, 6H, Xantphos CH3).
31P{1H} NMR (160 MHz, CD2Cl2). δ 20.4 [d,
1JRhP = 124 Hz].
ESI-MS (CH2Cl2) Positive Ion. [M]
+ m/z = 859.18 (calc. 859.18).
Microanalysis. C85H54BF24OP2Rh (1722.99) requires: C 59.25, H
3.16; found: C 59.17, H 3.05.
mer-[Rh(κ3-P,O,P-Xantphos)(ClCH2Cl)(σ,σ-(C6H4)C(H)CPh)]-
[BArF4] (7). 1a (246 mg, 0.15 mmol) was dissolved in dichloro-
methane (5 mL), and the solution was exposed to H2 for 30 min (1
atm). Then the solution was degassed by evaporation to dryness,
diphenylacetylene (107 mg, 0.60 mmol) in CH2Cl2 (5 mL) added, and
the mixture was stirred for 1h. The solution was evaporated and
washed with hexane, The solid product was recrystallized with
dichloromethane and hexane at −18 °C. Total yield =70%, 180 mg.
The two products 6 and [Rh(κ3-POP-Xantphos)(ClCH2Cl)(σ,σ-
(C6H4)C(H)CPh)][BArF4] 7 were observed by NMR spectrocopy,
the ratio being 1:2 respectively. Crystals of 7 suitable for X-ray
diﬀraction were obtained from dichloromethane solution with pentane
at −18 °C.
1H NMR (400 MHz, CD2Cl2). δ 8.00 (d, J = 7.6 Hz, 2H), 7.77−7.69
(m, 8H BArF4), 7.60−7.13 (m, 25H), 7.00 (t, J = 7.6 Hz, 4H), 6.79−
6.70 (m, 4H), 6.48 (t, J = 7.6 Hz, 1H), 6.38 (d, J = 2.8 Hz,, 1H), 6.21
(d, J = 7.2 Hz, 1H), 6.13 (t, J = 7.6 Hz, 1H), 6.05−6.01 (m, 1H), 2.11
(s, 3H, Xantphos CH3), 1.70 (s, 3H, Xantphos CH3). (coordinated
dichloromethane was not observed.)
31P{1H} NMR (160 MHz, CD2Cl2). δ 27.2 [d,
1JRhP = 119 Hz].
ESI-MS (CH2Cl2) Positive Ion. [M]
+ m/z = 859.17 (calc. 859.18).
[Rh(κ3-P,O,P-Xantphos)(σ,κ
1-C6H4COMe)(SMe)][BAr
F
4] (8). A
solution of 6 (8 mg, 4.6 × 10−3) and 2-(methylthio)acetophenone
in D-toluene (0.5 mL) was prepared in a J. Young NMR tube and
analyzed in situ by NMR spectroscopy at room temperature. A mixture
of mer-[Rh(κ3-POP-Xantphos)(σ,κ1-C6H4COMe)(SMe)][BAr
F
4]
(mer-8) and fac-[Rh(κ3-POP-Xantphos)(σ,κ1-C6H4COMe)(SMe)]-
[BArF4] ( fac-8) was formed in the ratio of 1:20 after 20 min. The
ratio of fac-8 increased continually, so that after 32 h fac-8 was the only
observed Rh complex.
mer-8 can be isolated in pure form with the following procedure:
To a J. Youngs tube containing 6 (258 mg, 0.15 mmol), 1-(2-
(methylthio)phenyl)ethanone (55 mg, 0.33 mmol) was added 5 mL
toluene, sealed and the resulting solution was stirred for 40 min at 100
°C. The solution was concentrated to dryness under vacuum, the
resulting residue washed with pentane, then recrystallized by diﬀusion
of pentane into a 1,2-diﬂuorobenzene solution of the crude product at
−18 °C to yield orange crystals. Yield = 70%, 180 mg.
Data for mer-8. 1H NMR (400 MHz, CD2Cl2). δ 8.06 (d, J = 8.0 Hz,
1H, Ar−H), 7.93 (dd, J = 7.6 Hz, J = 2.0 Hz 2H, Ar−H), 7.82−7.76
(m, 4H Ph), 7.74−7.70 (m, 8H BArF4), 7.62−7.47 (m, 10H Ar−H +
BArF4), 7.47−7.39 (m, 5H Ar−H), 7.33 (t, J = 7.6 Hz, 2H Ph′), 7.26
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(dd, J = 8.0 Hz, J = 1.6 Hz, 1H, Ar−H), 7.18−7.11 (m, 5H), 6.71−
6.64 (m, 4H, Ph′) 1.99 (s, COMe 3H), 1.78 (s, Xantphos CH3 3H),
1.32 (s, Xantphos CH3 3H), 0.87 (s, SMe 3H).
31P{1H} NMR (160 MHz, CD2Cl2). δ 23.8 [d,
1JRhP = 106 Hz].
ESI-MS (CH2Cl2) Positive Ion. [M]
+ m/z = 847.14 (calc. 847.14).
Microanalysis. C80H54BF24O2P2RhS (1710.99) requires: C 56.16, H
3.18; found: C 55.93, H 3.16.
Data for fac-8. 1H NMR (400 MHz, D-Toluene). δ 8.37−6.09 (m,
42H), 1.56 (d, J = 7.6 Hz, 3H, SMe), 1.48 (s, Xantphos CH3, 3H),
1.43 (d, J = 1.2 Hz, 3H), 1.39 (s, Xantphos CH3, 3H).
31P{1H} NMR (160 MHz, D-Toluene). δ 34.8 [dd, 1JRhP = 150 Hz,
2JPP
= 17 Hz], 22.6 [dd, 1JRhP = 104 Hz,
2JPP = 17 Hz].
mer-[Rh(κ3-P,O,P-Xantphos)(σ,κ
1-C6H4COOMe)(SMe)][BAr
F
4]
(9). To a J. Youngs tube containing 6 (100 mg, 0.06 mmol), methyl 2-
(methylsulfanyl)benzoate (13 mg, 0.07 mmol) was added 10 mL
chlorobenzene, sealed and the resulting solution was stirred for 30 min
at 80 °C. The solution was concentrated to dryness under vacuum, the
resulting residue washed with pentane, then recrystallized by diﬀusion
of pentane into a dichloromethane solution of the crude product at
−18 °C to yield brown crystals. Yield =77%, 80 mg.
1H NMR (400 MHz, CD2Cl2). δ 8.00 (d, J = 8.0 Hz, 1H, Ar−H), 7.94
(d, J = 7.2 Hz, 2H, Ar−H), 7.90−7.81 (m, 4H Ph), 7.74−7.71 (m, 8H
BArF4), 7.64−7.51 (m, 10H Ar−H + BArF4), 7.49−7.41 (m, 5H Ar−
H), 7.36 (t, J = 6.8 Hz, 3H Ar−H), 7.26−7.11 (m, 5H Ar−H), 6.77−
6.69 (m, 4H, Ph′) 2.82 (s, COOMe 3H), 1.96 (s, Xantphos Me 3H),
1.82 (s, Xantphos Me 3H), 0.85 (s, SMe 3H).
31P{1H} NMR (160 MHz, CD2Cl2). δ 22.2 [d,
1JRhP = 106 Hz].
ESI-MS (CH2Cl2) Positive Ion. [M]
+ m/z = 863.14 (calc. 863.14).
Microanalysis. C80H54BF24O3P2RhS (1726.99) requires: C 55.64, H
3.15; found: C 55.55, H 3.07.
mer-[Rh(κ3-P,O,P-Xantphos)(σ,κ
1-C6H4NO2)(SMe)][BAr
F
4] (10).
To a ﬂask containing 6 (100 mg, 0.06 mmol), 2-nitrothioanisole (10
mg, 0.06 mmol) was added 15 mL dichloromethane, the resulting
solution was stirred for 24 h room temperature. The solution was
concentrated to dryness under vacuum, the resulting residue washed
with pentane, then recrystallized by diﬀusion of pentane into a 1,2-
diﬂuorobenzene solution of the crude product at −18 °C to yield
brown crystals. Yield = 66%, 68 mg.
1H NMR (400 MHz, CD2Cl2). δ 8.14 (d, J = 8.0 Hz, 1H, Ar−H),
7.96−7.94 (m, 2H), 7.79−7.68 (m, 12H, Ar−H + BArF4), 7.65−7.54
(m, 11H Ar−H + BArF4), 7.47 (t, J = 7.6 Hz, 4H Ar−H), 7.39−7.34
(m, 3H Ar−H), 7.21 (t, J = 7.6 Hz, 1H Ar−H), 7.15 (t, J = 7.6 Hz, 4H
Ar−H), 6.81−6.75 (m, 4H, Ph′), 1.98 (s, Xantphos Me 3H), 1.77 (s,
Xantphos Me 3H), 0.88 (s, SMe 3H).
31P{1H} NMR (160 MHz, CD2Cl2). δ 23.1 [d,
1JRhP = 102 Hz].
ESI-MS (CH2Cl2) Positive Ion. [M]
+ m/z = 850.12 (calc. 850.12).
Microanalysis. C78H51BF24NO3P2RhS (1713.95) requires: C 54.66,
H 3.00, N 0.82; found: C 54.57, H 2.87, N 0.86.
mer−[Rh(κ3-P,O,P-Xantphos)(σ,κ1-2-(2-oxazolinyl)phenyl)-
(SMe)][BArF4] (11). To a J. Youngs tube containing 6 (100 mg, 0.06
mmol), 2-(2-(methylthio)phenyl-4,5-dihydrooxazole (14 mg, 0.07
mmol) was added 10 mL chlorobenzene, sealed and the resulting
solution was stirred for 60 min at 100 °C. The solution was
concentrated to dryness under vacuum, the resulting residue washed
with pentane, then recrystallized by diﬀusion of pentane into a
dichloromethane solution of the crude product at −18 °C to yield
orange crystals. Yield =78%, 81 mg.
1H NMR (400 MHz, CD2Cl2). δ 7.99−7.86 (m, 7H), 7.76−7.69 (m,
8H, BArF4), 7.67−7.55 (m, 8H Ar−H + BArF4), 7.51 (t, J = 7.6 Hz, 2H
Ar−H), 7.44−7.30 (m, 8H Ar−H), 7.29−7.20 (m, 5H Ar−H), 6.72−
6.63 (m, 4H, Ph), 3.32 (t, J = 9.6 Hz, 2H oxazoline CH2), 2.35 (t, J =
9.6 Hz, 2H oxazoline CH2), 1.94 (s, Xantphos Me 3H), 1.72 (s,
Xantphos Me 3H), 0.84 (s, SMe 3H).
31P{1H} NMR (160 MHz, CD2Cl2). δ 17.8 [d,
1JRhP = 103 Hz].
ESI-MS (CH2Cl2) positive ion. [M]
+ m/z = 874.16 (calc. 874.15).
Microanalysis. C81H55BF24NO2P2RhS (1738.02) requires: C 55.98,
H 3.19, N 0.81; found: C 56.04, H 3.09, N 0.78.
mer-[Rh(κ3-P,O,P-Xantphos)(σ,κ
1-2-(2-pyridyl)phenyl)(SMe)]-
[BArF4] (12). To a J. Youngs tube containing 6 (25 mg, 0.015 mmol),
2-(2-(methylthio)phenylpyridine (4 mg, 0.02 mmol) was added 10
mL chlorobenzene, sealed and the resulting solution was stirred for 3 h
at 80 °C. The solution was concentrated to dryness under vacuum, the
resulting residue washed with pentane, then recrystallized by diﬀusion
of pentane into a dichloromethane and toluene mixture solution of the
crude product at −18 °C to yield red crystals. Yield = 69%, 18 mg.
1H NMR (400 MHz, CD2Cl2). δ 8.05 (d, J = 7.6 Hz, 1H), 7.96 (dd, J
= 7.2 Hz, J = 1.6 Hz 2H), 7.91−7.82 (m, 4H), 7.76−7.70 (m, 8H
BArF4), 7.64−7.12 (m, 20H), 7.12−7.03 (m, 3H), 6.82 (t, J = 7.6 Hz,
4H), 6.43−6.34 (m, 4H, Ph), 1.92 (s, Xantphos Me 3H), 1.90 (s,
Xantphos Me 3H), 0.88 (s, SMe 3H).
31P{1H} NMR (160 MHz, CD2Cl2). δ 20.1 [d,
1JRhP = 105 Hz].
ESI-MS (CH2Cl2) Positive Ion. [M]
+ m/z = 882.16 (calc. 882.16).
Microanalysis. C83H55BF24NOP2RhS (1746.04) requires: C 57.10,
H 3.19, N 0.80; found: C 57.20, H 3.16, N 0.87.
fac-[Rh(κ3-P,O,P-Xantphos)(η
3-C3H5)(SPh)][BAr
F
4] (13). To a J.
Youngs tube containing 6 (100 mg, 0.06 mmol), allyl phenyl sulﬁde
(19 mg, 0.12 mmol) was added 10 mL chlorobenzene, sealed and the
resulting solution was stirred for 2 h at 80 °C. The solution was
concentrated to dryness under vacuum, the resulting residue washed
with pentane, then recrystallized by diﬀusion of pentane into a
dichloromethane solution of the crude product at −18 °C to yield
green crystals. Yield = 60%, 61 mg.
1H NMR (400 MHz, CD2Cl2). δ 7.88−7.78 (m, 4H), 7.77−7.62 (m,
10H), 7.66−7.48 (m, 14H), 7.23−7.12 (m, 3H), 7.08−6.99 (m, 4H),
6.92−6.88 (m, 4H), 6.82 (t, J = 7.6 Hz, 2H), 6.66 (d, J = 7.6 Hz, 2H),
4.80 (quintet, J = 10.0 Hz, 1H CH C3H5), 4.05−3.93 (m, 2H CH2
C3H5), 2.71−2.57 (m, 2H CH2 C3H5), 1.95 (s, Xantphos Me 3H),
1.30 (s, Xantphos Me 3H).
31P{1H} NMR (160 MHz, CD2Cl2). δ 22.7 [d,
1JRhP = 132 Hz].
ESI-MS (CH2Cl2) Positive Ion. [M]
+ m/z = 831.15 (calc. 831.15).
Microanalysis. C80H54BF24OP2RhS (1695.00) requires: C 56.69, H
3.21; found: C 56.84, H 3.17.
mer-[Rh(κ3-P,O,P-Xantphos)(σ,κ
1-(COMe)C6H3SMe)(H)][BAr
F
4]
(14). To a J. Youngs tube containing 6 (80 mg, 0.046 mmol), 4-
(methylthio)acetophenone (11.5 mg, 0.069 mmol) was added 10 mL
toluene, the resulting solution was stirred for 2 days at room
temperature. The solution was ﬁltered, and then concentrated to
dryness under vacuum, the resulting residue washed with pentane,
then recrystallized by diﬀusion of pentane into a chlorobenzene
solution of the crude product at −18 °C to yield colorless crystals.
Yield =38%, 30 mg.
1H NMR (400 MHz, CD2Cl2). δ 8.02−7.94 (m, 4H), 7.79 (dd, J = 7.6
Hz, J = 2.0 Hz 3H), 7.77−7.68 (m, 9H), 7.63−7.56 (m, 10H), 7.47−
7.35 (m, 6H), 7.24−7.17 (m, 7H), 6.78 (dd, J = 8.4 Hz, J = 1.6 Hz,
1H), 6.69−64 (m, 3H), 2.33 (s, 3H), 1.86 (s, 3H), 1.77 (s, 3H), 1.43
(s, 3H), −14.99 (dt, JRhH = 29.2 Hz, JPH = 10.8 Hz, 1H)
31P{1H} NMR (160 MHz, CD2Cl2). δ 39.5 [d,
1JRhP = 114 Hz].
ESI-MS (Acetone) Positive Ion. [M]+ m/z = 847.15 (calc. 847.15).
Microanalysis. C80H54BF24O2P2RhS (1710.99) requires: C 56.16, H
3.18; found: C 56.38, H 3.01.
Crystallography. X-ray crystallography data were collected on an
Agilent SuperNova diﬀractometer using graphite monochromated Cu
Kα radiation (λ = 1.54180 Å), or an Enraf Nonius Kappa CCD
diﬀractometer using Mo Kα radiation (λ = 0.71073 Å) with the use of
low-temperature devices [150(2) K].61 Data were reduced using the
instrument manufacturer software, DENZO-SMN,62,63 and Crystal-
Clear. All structures were solved ab initio using SIR92,64 or
SuperFlip,65 and the structures were reﬁned using CRYSTALS66 or
SHELX.67 All non-hydrogen atoms were reﬁned with anisotropic
displacement parameters. All hydrogen atoms were placed in
calculated positions using the riding model unless otherwise stated.
Crystallographic data have been deposited with the Cambridge
Crystallographic Data Center under CCDC 1025603−1025612.
These data can be obtained free of charge from The Cambridge
Crystallographic Data Center via www.ccdc.cam.ac.uk/data_request/
cif.
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